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Abstract: A sedentary lifestyle is a major modifiable risk factor for many chronic diseases. Lifestyle
modification in order to increase exercise capacity is key in the prevention and rehabilitation of chronic
diseases. This could be achieved by active commute. The aim of this study was to assess the effects of
daily active commuting on physical activity (PA) and exercise capacity. Seventy-three healthy hospital
employees (age: 46 ± 9 years, 38% male), with a predominantly passive way of commuting, were randomly
assigned to two parallel groups, a control group (CG, N = 22) or an intervention group (IG, N = 51), which
was further split into public transportation/active commuting (IG-PT, N = 25) and cycling (IG-C, N =
26). Both intervention groups were asked to reach 150 min/wk of moderate- to vigorous-intensity exercise
during their commute for 1 year. CG maintained a passive commuting mode. All participants underwent
assessment of anthropometry, risk factor stratification, and exercise capacity by a medical doctor at
the Institute of Sports Medicine, Prevention and Rehabilitation. Weekly physical activity, using the
International Physical Activity Questionnaire and commuting behavior, using an online diary, were used
to assess physical activity. At the end of the study, the change in exercise capacity did significantly differ
between IG and CG (P = .003, ES = 0.82). Actively covered distances through commuting significantly
differed between groups (walking P = .026; cycling P < .001). Therefore, active commuting improves
exercise capacity and can be recommended to the working population to increase exercise capacity.
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1 |  INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death in the 
industrialized world.1 Risk factors for CVD are manifold. One 
major risk factor for CVD but also for many other non-commu-
nicable diseases is a sedentary lifestyle. Lifestyle modification in 
the sense of being more active and increasing exercise capacity 
is key not only in the treatment of patients suffering from CVD 
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A sedentary lifestyle is a major modifiable risk factor for many chronic diseases. 
Lifestyle modification in order to increase exercise capacity is key in the prevention 
and rehabilitation of chronic diseases. This could be achieved by active commute. 
The aim of this study was to assess the effects of daily active commuting on physical 
activity (PA) and exercise capacity. Seventy-three healthy hospital employees (age: 
46 ± 9 years, 38% male), with a predominantly passive way of commuting, were 
randomly assigned to two parallel groups, a control group (CG, N = 22) or an inter-
vention group (IG, N = 51), which was further split into public transportation/active 
commuting (IG-PT, N = 25) and cycling (IG-C, N = 26). Both intervention groups 
were asked to reach 150 min/wk of moderate- to vigorous-intensity exercise during 
their commute for 1 year. CG maintained a passive commuting mode. All partici-
pants underwent assessment of anthropometry, risk factor stratification, and exercise 
capacity by a medical doctor at the Institute of Sports Medicine, Prevention and 
Rehabilitation. Weekly physical activity, using the International Physical Activity 
Questionnaire and commuting behavior, using an online diary, were used to assess 
physical activity. At the end of the study, the change in exercise capacity did signifi-
cantly differ between IG and CG (P = .003, ES = 0.82). Actively covered distances 
through commuting significantly differed between groups (walking P =  .026; cy-
cling P < .001). Therefore, active commuting improves exercise capacity and can be 
recommended to the working population to increase exercise capacity.
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but also in the prevention of CVD and other non-communica-
ble disease. Already a modest increase in physical activity (PA)2 
leads to substantial improvement in exercise capacity and health 
in general.3-6 Indeed, moderate- to vigorous-intensity physical 
activity has been shown to offset the health risk of extended 
hours of inactivity, that is, reduces all-cause and CVD mortal-
ity.7 If a certain amount of PA is not reached, exercise capacity 
will decrease, which is associated with increased mortality.5,6 
Despite the benefits of PA which are well understood and pro-
moted not only by the World Health Organization (WHO)8 and 
different medical associations,9-12 31% of the global population 
are physically inactive13 and the prevalence of insufficient physi-
cal activity still increases, especially in high-income countries.14 
The gap between being active and inactive is only 30 minutes 
a day. This small amount of time is enough to reduce the risk 
of all-cause mortality by 14% and results in a 3-year longer life 
expectancy.2 The knowledge of a healthy lifestyle itself is not 
enough, strategies need to be found to help people to get active 
at a proper level, and many national health authorities have al-
ready implemented strategies.15-17 Indeed, active commuting 
has already been reported to be effective in improving exercise 
capacity.18,19 Although active commuting in combination with 
promotion via new technologies is “en vogue” and may at least 
in part solve the pandemic of physical inactivity20 as well as pos-
sible transportation problems in cities, randomized controlled 
trials are still lacking to prove the effectiveness of active com-
muting on various risk factors and especially physical activity 
and exercise capacity. It was therefore the goal of this study to 
assess the effects on cardiovascular risk factors, especially on 
physical activity and exercise capacity through employer-trig-
gered interventions to meet the World Health Organization 
(WHO) recommendations of moderately exercising 150 minutes 
a week8 while commuting. We hypothesized that implementing 
the WHO recommendation for exercise into the daily commute 
would increase physical activity and exercise capacity.
2 |  METHODS
This study utilized a 2:1 randomized, control group design 
consisting of an intervention group (with two different ways 
to promote active commuting according to the distance of the 
participant and the working place) and a control group, to de-
velop a framework for future studies on active commuting.21
2.1 | Study approval and design
The GISMO (Geographical Information Support for healthy 
MObility) study complied with the Declaration of Helsinki 
and its current amendments and was approved by the Ethical 
Committee of the Paris Lodron University Salzburg, Austria 
(EK-GZ: 43/2016). The trial is registered at Clini calTr ials.
gov (NCT03098719). All participants provided written in-
formed consent before study inclusion.
2.2 | Subjects
Employees of the hospitals of the State of Salzburg (Salzburger 
Landeskliniken, SALK, Austria) between 18 and 75 years who 
were able to properly understand the protocol in German, moti-
vated to change their commuting habits, and willing to take part 
in the study over 1 year were considered for inclusion. Subjects 
with known physical or psychiatric conditions precluding regu-
lar physical exercise were excluded. In particular, the following 
conditions were considered not to be compatible with the study: 
simultaneous or <4-week participation in other clinical stud-
ies, pregnancy or lactation, known musculo-skeletal conditions 
impairing mobility, subjects with known depression or other 
psychiatric disorders in the last 5 years prior to enrollment (ie, 
panic, obsessive-compulsive disorder, schizophrenia, organic 
mental disorder, psychotic, phobic conditions), osteoporosis in 
need of treatment, severe general diseases (neoplasia, tubercu-
losis, heart failure), chronic infections, and subjects with active 
alcohol or drug abuse or addiction. Subjects interested in our 
study contacted our research administrator and were considered 
if they were motivated to commute actively using public trans-
port as well as cycling or walking. An analysis of the screening 
process of this study is provided elsewhere,22 and a flowchart of 
the study is shown in Figure 1.
2.3 | Randomization
Randomization was performed with a 2:1 stratum to an inter-
vention group (IG) and a control group (CG). Eighty envelopes 
were filled with 54 lots for IG and 26 for CG. At study entry, 
each participant picked a sealed envelope showing him his 
group assignment. Unused envelopes were discarded (n = 7).
2.4 | Data acquisition
Data were collected at the beginning and end of the study 
from adherent participants to allow assessment of the effects 
of regular active commuting on cardiovascular risk profile, 
daily activity, physical performance, quality of life, mobility 
behavior, and body composition. Non-adherent participants 
did not continue to commute actively. All investigations were 
pre-specified in the ethics protocol and on Clini calTr ials.gov.
At all time points, subjective effects of active commuting 
were analyzed by questionnaires: SF-36 questionnaire, to ex-
plore the quality of life; IPAQ (International Physical Activity 
Questionnaire), to estimate the amount of daily physical ac-
tivity; and a questionnaire about mobility (see Appendix S1). 
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The Heart Score of the European Society of Cardiology was 
utilized to analyze cardiovascular risk factors.23 Blood tests 
including lipid values and HbA1c measurements were per-
formed in fasting condition after 10 minutes of resting and 
were immediately handed over to the laboratory for further 
analysis. An electrocardiogram (ECG) was performed using 
AmedTec ECGpro software and hardware. Anthropometric 
measurements included height, weight, body mass index, ab-
dominal circumference measured above the hips, and analy-
sis of body fat composition using the 4-point measurements 
of skinfold thickness, with the Harpenden calliper24 at the 
following landmarks: (a) m. triceps brachii, (b) m. biceps 
brachii, (c) subscapularly (under the angulus inferior), and 
(d) abdominal (pinch placed vertically 5cm adjacent to the 
umbilicus to the right side); for each position, the average of 
three measurements was taken.
In accordance with respective guidelines, physical ex-
amination, personal history, and a 12-lead resting ECG and 
a spirometry at rest were performed in every subject before 
ergometry by a medical doctor at the Institute of Sports 
Medicine, Prevention and Rehabilitation, Salzburg. The in-
stitute has a volume of approximately 2500 patients per year. 
Ergometries were performed to assess the primary outcome of 
the study, that is, exercise capacity. Exercise protocols were in 
accordance with the Austrian guidelines of exercise testing25 
and kept identical for male and female participants during all 
tests to permit accurate comparison. Male participants started 
a ramp protocol at 60  W, and performance was increased 
F I G U R E  1  Flowchart of the study
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every minute by 20 W; female participants started at 40 W 
with a 15W increase every minute. During ergometry, a 12-
lead electrocardiogram (ECG) continuously monitored heart 
rate; blood pressure was measured manually at rest and sub-
sequently during ergometry. In all participants, ergometries 
were stopped when volitional exhaustion or pre-specified cri-
teria for termination (listed elsewhere25) were reached.
Mobility characteristics were recorded by mobility di-
aries, which were validated and corrected with the help of 
GPS-equipped fitness watches (Polar M200). Participants 
were asked to wear these devices during 2 weeks at the begin-
ning and 2 weeks toward the end of the intervention period. 
With this combined approach, the validity of the mobility 
documentation could have been increased substantially com-
pared to self-reported approaches.26
2.5 | Intervention
Intervention group A (IG-PT) included participants who lived 
further away, and in addition to using public transportation, 
they were expected to get off at least one stop further away 
from work and home as they usually would. Also, they were 
asked to walk the remaining distance. Alternatively, partici-
pants could also use a bicycle to cover this distance. As part of 
this intervention, tickets for the study duration were provided 
as an incentive to switch from cars to public transportation.
Intervention group B (IG-C) included those participants 
who lived ≤10 km from work. These participants were ex-
pected to change from car to cycling and/or walking for at 
least 50% of the total commuting distance. In case of bad 
weather or exceptional circumstances, it was allowed to use 
the car or public transportation.
Control group: Participants allocated to the control group 
were asked to continue to commute as usual. A total of 20-25 
participants in each group were needed to complete the study.
Participants reported their commuting details, which were 
periodically verified by GPS tracking.
However, both groups were asked to reach the WHO 
recommendation of 150 minutes of at least moderate exer-
cise intensity during their commute for 1 year, whereas CG 
was asked not to change their mode of commuting. Each 
group received incentives to keep them motivated, and 
participants were randomized to the intervention group to 
refrain from using the car to commute; for example, all par-
ticipants had the opportunity to have their bicycles repaired 
free of charge, received rain gear, and other useful items.22
2.6 | Statistical analysis
All variables were tested for normal distribution by the 
Kolmogorov-Smirnov or Shapiro-Wilk test. As all variables 
were normally distributed, data are shown as mean and 95% 
confidence intervals (CI), or standard deviation (STD), 
mean, and 95% CI of the delta between the beginning and end 
of the study. Differences in baseline characteristics between 
groups were assessed by independent t tests and chi-square 
test as appropriate. Per-protocol analysis was performed 
with ANOVA for PA and ANCOVA accounting for baseline 
values and sex, to assess differences between groups. 
Subsequent post-hoc analysis was tested with Bonferroni 
correction. A two-sided P-value of .05 was considered to be 
statistically significant. Effect size (ES) was calculated as the 
mean of IG – mean of CG divided by the standard deviation 
of the pooled values of all participants. All statistical analyses 
were performed with IBM SPSS Statistics version 21 (SPSS, 
Inc). No a priori sample size calculation was performed since 
the sample size was defined by the willingness of includable 
hospital staff to participate in the study. However, great effort 
was undertaken to recruit as many participants as highlighted 
by the recruitment process provided elsewhere.22
3 |  RESULTS
Seventy-seven healthy hospital employees were assessed for 
eligibility; four subjects were excluded or declined to par-
ticipate, and 11 dropped out during the intervention period. 
Finally, 17 patients were analyzed in CG, 23 participants in 
IG-PT, and 22 participants in IG-C. Participants worked in 
all hospital areas (21 nurses [34%], nine physicians [15%], 
20 working in administration [32%], and 12 in various other 
professions [19%]). Baseline characteristics are shown in 
Table  1. Distances covered through active commuting sig-
nificantly differed between groups, and an increase in PA, 
measured with IPAQ, did not reach the level of significance 
(Table 2).
Changes in exercise capacity during the study signifi-
cantly differed between IG (14 W [95% CI: 6, 22] P = .003, 
ES = 0.82) and CG (−8 W [95% CI: −19, 3]). Exercise ca-
pacity at the end of the study significantly differed between 
IG (239 W [95% CI: 213, 264] P = .003, ES = 0.47) and CG 
(202 W [95% CI: 175, 229]) as well as between IG-PT and 
IG-C and CG (P = .013). A Bonferroni post-hoc test revealed 
that exercise capacity was statistically different compared to 
IG-PT (216 W [95% CI: 186, 247] P = .032, ES = 0.18) and 
IG-C (262 W [95% CI: 220, 305] P = .025, ES = 0.76) and 
CG (Figure 2; Table 2).
Changes in Pmaxrel during the study significantly differed 
between IG (9% [95% CI: 5, 14] P < .001, ES = 0.95) and 
CG (−6% [95% CI: −13, 0]). Pmaxrel at the end of the study 
significantly differed between IG (154% [95% CI: 145, 163], 
P <  .001, ES = 0.60) and CG (136% [95% CI: 123, 148]) 
as well as between IG-PT and IG-C and CG (P = .003). A 
Bonferroni post-hoc test revealed that Pmaxrel was statistically 
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T A B L E  1  Baseline characteristics of the control group (CG), public transportation/active commuting (IG-PT), and cycling (IG-C)
ALL (N = 62) CG (N = 17) IG-PT (N = 23) IG-C (N = 22)
Age (y) 46 [9] 45 [10] 47 [9] 47 [8]
Men (%) 36 29 30 45
Anthropometrics
Height (m) 1.71 [0.1] 1.71 [0.1] 1.69 [0.1] 1.74 [0.1]
Weight (kg) 76.5 [16.5] 77.7 [20.3] 73.5 [14.5] 78.7 [15.4]
BMI (kg/m2) 26.0 [4.5] 26.4 [5.5] 25.8 [4.4] 26.0 [4.0]
Waist circ. (cm) 91.1 [13.2] 92.6 [16.3] 89.1 [11.5] 91.9 [12.5]
Hip circ. (cm) 103.2 [11.3] 101.8 [13.2] 103.3 [12.6] 104.1 [8.4]
Waist-to-hip ratio 0.9 [0.1] 0.9 [0.1] 0.9 [0.1] 0.9 [0.1]
Body fat (%) 34.6 [0.8] 35.0 [9.1] 35.0 [7.6] 34.0 [7.9]
Spirometry
FVC (L) 4.1 [1.0] 4.0 [0.7] 4.0 [1.0] 4.3 [1.1]
FEV1 (L) 3.2 [0.8] 3.1 [0.7] 3.1 [0.8] 3.4 [1.0]
PEF (L) 7.8 [2.2] 7.6 [1.9] 7.3 [2.0] 8.4 [2.5]
FEV1/FVC 0.8 [0.1] 0.8 [0.1] 0.8 [0.1] 0.8 [0.1]
Lipid and glucose metabolism
TRI (mg/dL) 90.9 [43.4] 86.0 [51.4] 98.0 [40.5] 87.2 [40.5]
CHOL (mg/dL) 205.3 [34.3] 200.2 [38.6] 211.8 [35.8] 202.4 [29.4
HDL (mg/dL) 74.3 [23.8] 83.7 [34.6] 68.4 [17.4] 73.1 [17.6]
LDL (mg/dL) 113.4 [30.7} 101.1 [21.8] 123.9 [35.9] 112.0 [27.9]
LDL/HDL ratio 1.7 [0.8] 1.4 [0.6] 2.0 [0.9] 1.6 [0.6]
HbA1c (%) 5.3 [0.3] 5.3 [3.4] 5.3 [0.2] 5.4 [0.3]
GLU (mg/dL) 78.0 [13.0] 78.2 [13.3] 75.3 [10.3] 80.7 [15.1]
Cardiovascular risk scores
FRS score 2.4 [3.0] 3.0 [4.4] 2.2 [2.4] 2.1 [2.1]
HS score 0.5 [0.7] 0.6 [0.9] 0.5 [0.7] 0.5 [0.4]
Blood pressure
RRsys (mm Hg) 114 [13] 114 [14] 112 [10] 117 [15]
RRdia (mm Hg) 72 [11] 71 [9] 71 [9] 75 [13]
Exercise capacity
Pmax (W) 221 [70] 210 [56] 203 [58] 248 [85]
Pmaxrel (%) 144 [25] 142 [25] 138 [22] 152 [27]
HRmax (bpm) 171 [13] 171 [14] 171 [12] 172 [14]
HRrest (bpm) 63 [9] 66 [9] 63 [5] 62 [11]
BORG 19.1 [0.4] 19.1 [0.3] 19.0 [0.4] 19.1 [0.4]
IPAQ
Total PA (METmin-1) 4166 [4431] 5251 [5076] 3143 [3725] 4398 [4550]
Walk (METmin-1) 1370 [2115] 1427 [1848] 1053 [1262] 1657 [2919]
Mod (METmin-1) 1015 [1631] 1121 [2251] 540 [738] 1428 [1691]
Vig (METmin-1) 1782 [2391] 2703 [3068] 1550 [2612] 1313 [1141]
Sit (min) 377 [167] 346 [151] 411 [205] 367 [133]
Note: Data are shown as mean [SD].
Abbreviations: BMI, body mass index; BORG, rating of perceived exertion; CHOL, total cholesterol; FEV1, forced expiratory volume in the 1st second; FRS score, 
Framingham risk score; FVC, forced vital capacity; GLU, fasting blood glucose; HbA1c, hemoglobin A1c; HDL, HDL cholesterol; Hip circ., hip circumference; 
HRmax, maximal heart rate at ergometry; HRrest, resting heart rate; HS score, Heart Score of the European Society of Cardiology (ESC); IPAQ, International Physical 
Activity Questionnaire; LDL, LDL cholesterol; Mod, moderate-intensity activities within the last 7 d; N, number of participants; PEF, peak expiratory flow; Pmax, 
exercise capacity; Pmaxrel, age and weight-normalized exercise capacity; PT, public transportation; RRdia, diastolic blood pressure; RRsys, systolic blood pressure; Sit, 
sitting time during the last 7 d; Total PA, total physical activities during the last 7 d; TRI, triglycerides; Vig, vigorous-intensity activities within the last 7 d; Waist 
circ., waist circumference; Walk, walking within the last 7 d.
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different compared to IG-PT (147% [95% CI: 123, 148], 
P = .003, ES = 0.37) and IG-C (162% [95% CI: 147, 176], 
P = .025, ES = 0.86) and CG (Figure 2; Table 2).
Neither HRmax nor the BORG scale did significantly dif-
fer between groups (P  =  .111 and P  =  .204, respectively) 
(Figure 2; Table 2).
4 |  DISCUSSION
The results of the GISMO study show that the change to 
active commuting increases PA and exercise capacity. Both 
intervention groups, but not CG, which did not commute 
actively, significantly improved exercise capacity. PA, in the 
T A B L E  2  Change in exercise capacity, IPAQ and covered distances of study participants of the control group (CG), public transportation/
active commuting (IG-PT), and cycling (IG-C)
CG (N = 17) IG-PT (N = 23) ES IG-C (N = 22) ES P
Pmax (W) −8 [−19, 3] 13 [4, 23] 0.78 14 [1, 28] 0.82 .013
Pmaxrel (%) −6 [−13, 0] 9 [3, 15] 0.92 10 [1, 18] 0.97 .003
HRmax (bpm) −4 [−10, 2] 3 [0, 7] 0.61 2 [−4, 8] 0.52 .111
BORG −0.1 [0, 0] 0.0 [0, 0.1] 0.35 −0.1 [−0.2, 0] 0.00 .204
IPAQ
Total PA (METmin−1) 717 [−1717, 3150] 3200 [1546, 4853] 0.50 3466 [855, 6078] 0.57 .295
Walk (METmin−1) 221 [−633, 1074] 814 [−85, 1712] 0.23 712 [−881, 2305] 0.19 .400
Mod (METmin−1) 674 [−566, 1913] 1117 [206, 2028] 0.05 453 [−129, 1034] −0.12 .944
Vig (METmin−1) −178 [−1538, 1183] 1269 [170, 2368] 0.46 2302 [583, 4020] 0.78 .129
Sitting (min) 23 [−80, 126] −61 [−171, 48] 0.32 −52 [−101, −3] −0.39 .442
Covered distances PANOVA
Walking (km) 110 [19, 202] 305 [203, 407] 0.91 65 [12, 119] −0.21 <.001
Cycling (km) 35 [0, 73] 450 [185, 716] 0.39 1673 [1159, 2187] 1.56 <.001
PT (km) 273 [0, 681] 1861 [357, 3366] 0.54 1248 [0, 2642] 0.33 .230
Car (km) 2371 [30, 4711] 299 [73, 526] −0.90 322 [29, 616] −0.89 .016
Note: Data are mean differences of end-beginning [95% CI].
Abbreviations: BORG, rating of perceived exertion; ES, effect size between CG and IG-PT/IG-C; HRmax, maximal heart rate at ergometry; Mod, moderate-intensity 
activities within the last 7 d; P, ANCOVA adjusted for baseline and sex; Pmax, exercise capacity; Pmaxrel, age and weight-normalized exercise capacity; Sit, sitting time 
during the last 7 d; Total PA, total physical activities during the last 7 d; Vig, vigorous-intensity activities within the last 7 d; Walk, walking within the last 7 d.
F I G U R E  2  Exercise capacity at the 
beginning and end of study participants 
of the control group (CG), public 
transportation/active commuting (IG-PT), 
and cycling (IG-C). *P < .05 Pmax CG 
vs. IG-PT vs IG-C. CG, control group; 
IG-C, intervention group cycling; IG-PT, 
intervention group public transportation; 
Pmax, exercise capacity
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sense of active commuting, did significantly differ between 
groups. Based on our results, we can recommend active 
commuting to the working population to counteract physical 
inactivity and to increase exercise capacity.
As exercise capacity is one of the best prognostic factors 
for cardiovascular risk as well as all-cause morbidity and 
mortality, generally one benefits from an increased exercise 
capacity.27,28 For that reason, medical associations and pub-
lic authorities do recommend to stay or become physically 
active. People are aware of this fact as they rate the aspect of 
their lifestyle that they needed to change the most, “lack of 
exercise” as the highest.29
Not surprisingly, it is the sedentary person that benefits 
most from starting an exercise-training program, as already 
modest improvements in exercise capacity are associated 
with lower cardiovascular event rates.30 In our study, exercise 
capacity was improved by 7% in the IG-PT and by 6% in the 
IG-C, which is in accordance with shorter31 as well as lon-
ger32 interventions on active commuting. More interventions 
are addressed in a systematic review33 of intervention studies 
with active commuting as the primary intervention. Based on 
these studies, we can speculate that active commuting is also 
associated with lover cardiovascular event rates.34
Higher improvements in exercise capacity through com-
muting were reported by Hendriksen et al35 Fujimoto et al36 
reported a 19% increase in exercise capacity in previously 
sedentary, healthy seniors, enrolled in a 1-year training 
program. Also Howden et al37 documented in sedentary 
middle-aged participants a 19% improvement in exercise ca-
pacity after 2 years of exercise training. Increase in exercise 
capacity of such magnitude should not be expected if partici-
pants, who previously commuted passively to work, suddenly 
adopt an active mode of transportation, may it be by walking 
or cycling. To reach comparable improvement during studies 
of active commuting that are comparable to training studies, 
recommendations on duration and intensity have to be imple-
mented. Blond et al32 found that also in active commuters, 
gains in cardiorespiratory fitness increase with exercise in-
tensity. As Blond et al reported that the increase in physical 
fitness was steeper during the first than during the second 
3 months, this nicely illustrates the need to readjust exercise 
intensity and duration on a regular basis.
We assumed that weather would play an important role in 
activity behavior. We expected that especially cold and snowy 
winter conditions could be a barrier to physically active com-
muting. Surprisingly, this was not the case. Participants were 
active even during wintertime and did not use their cars more 
often than during summer. A detailed analysis on the sea-
sonal aspects of active commuting in the GISMO study is 
provided elsewhere.26 This is in contrast to Stigell et al38 who 
found lower cycling frequencies during winter than during 
summer. Walking commuters in contrast maintained active 
commuting also during winter. In our study, commuters con-
tinued to walk and cycle during winter, which possibly con-
solidated exercise capacity during this 1-year study.
Not only climate conditions, but probably even more im-
portantly the availability and quality of sidewalks and bike 
paths might be barriers for active commuters. Panter et al39 
reported that commuters who find a supportive environment 
for walking and cycling were more likely to incorporate walk-
ing or cycling into commuting. This was also true for people 
who had to pay for parking. Also Giles-Corti et al40 as well 
as Sallis et al41 called for better planning of cities to make ac-
tive transportation but also physical activity, in general, more 
attractive. Adequate infrastructure is fundamental for physi-
cally active commuting.42 On the other hand, one might argue 
that it is impossible for many employees to commute actively, 
as distances are too long. In this case, we recommend inter-
modal strategies with active parts in the trip chain.
The integration of exercise into one's daily routine is one 
way to overcome sedentary behavior. Thirty minutes of ac-
tive commuting should be possible for most people. Our re-
sults show that this is indeed feasible and that it significantly 
improves exercise capacity without needing to spend extra 
time. Time could even be saved as there is by far less time 
needed than it would take to go to the gym or take lessons 
with a personal coach or in a sports club. Interestingly, total 
time spent for commuting was not significantly higher during 
active as compared to passive commute.
In conclusion, lifestyle modification for prevention but also 
therapy is key in many chronic diseases. Recommendations 
of different medical associations and public health institu-
tions are similar but ineffective as activity levels in the in-
dustrialized world decrease.14 Effective and time-efficient 
strategies need to be developed to increase activity levels 
and exercise capacity. Active commuting is one option to in-
crease PA and to improve exercise capacity without spending 
extra time.
The strength of this study lies in the fact that it is a RCT 
in active commuting and that the collaboration between the 
medical field and geoinformatics fostered complementary 
insights and results. A limitation of our study is that on av-
erage, participants were at a low risk for lifestyle-related 
diseases. Also, they were all recruited from the same work-
place easily accessible by public transportation and by bike. 
Generalizability of our results is therefore difficult. There 
was no sample size calculation performed, since the funder 
had pre-defined the sizing of the trial. Criteria for relevant 
change or non-adherence were not defined prior to the begin-
ning of the study. Even though there were only few dropouts, 
our “per-protocol analyses” might have led to an overestima-
tion of results. The separation of IG into IG-PT and IG-C by 
searching for the best possible commute may have biased the 
randomization.
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In this randomized controlled study investigating the effects of 
active commuting, we can show beneficial effects on physical 
activity and exercise capacity. Based on our results as well as on 
other studies,32,43 active commuting may be recommended to 
policymakers, employers, employees, co-workers, or patients 
in order to improve physical activity and exercise capacity and 
to possibly even reduce mortality in the working force. On the 
one hand, much needs to be done with respect to infrastruc-
ture to make active commuting more attractive, as adequate 
infrastructure is fundamental for active commuting.42 Only 
then an increasing number of employees can benefit from its 
health effects. This will not only make people healthier but will 
generate multiple side effects, such as reducing the number of 
cars.40 On the other hand, more studies have to be performed to 
individualize recommendations on active commuting as well 
as duration and intensity of the commute. As most of the stud-
ies are observational studies, better improvements in exercise 
capacity and risk factors are potentially possible.
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